Список литературы

Поставить закладку

Куренков А.Л., Кузенкова Л.М., Никитин С.С., Бурсагова Б.И. Хроническая воспалительная демиелинизирующая полиневропатия у детей: диагностика и лечение. Вопросы современной педиатрии. 2014. Том 13. №5. – С. 34-41.
Cocito D., Grimaldi S., Paolasso I., Falcone Y. et al. Immunosuppressive treatment in refractory chronic inﬂammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis // Eur. J. Neurol. 2011. Vol. 18. P. 1417-1421
Comi C. Fas-mediated T-cell apoptosis in chronic inﬂammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2011;16 Suppl 1:45-47.
Dalakas M.C., Medscape. Advances in the diagnosis, pathogenesis and treatment of CIDP // Nat. Rev. Neurol. 2011. Vol. 7. P. 507-517.
Lehmann H.C., Burke D., Kuwabara S. Chronic inﬂammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment Journal of Neurology, Neurosurgery & Psychiatry 2019;90:981-987
Doneddu P.E., Bianchi E., Cocito D., et al. Risk factors for chronic inﬂammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. Eur J Neurol. 2020;27(1):136-143
Querol L., Crabtree M., Herepath M., et al. Systematic literature review of burden of illness in chronic inﬂammatory demyelinating polyneuropathy (CIDP) [published online ahead of print, 2020 Jun 24]. J Neurol. 2020;10.1007/s00415-020-09998-8. doi:10.1007/s00415-020- 09998-8
Markowitz J.A., Jeste S.S., Kang P.B. Child neurology: chronic inﬂammatory demyelinating polyradiculoneuropathy in children. Neurology. 2008;71:e74–e78.
Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society--ﬁrst revision. J Peripher Nerv Syst. 2010;15(3):185-195.
Куренков А.Л., Никитин С.С., Бурсагова Б.И., Кузенкова Л.М. Особенности хронической воспалительной демиелинизирующей полиневропатии у детей. Журнал «Нервно-мышечные болезни». 2012. №2. С. 40-51.
Никитин С.С., Куренков А.Л. Особенности острой воспалительной и хронической демиелинизирующих невропатий у детей. В книге: Аутоиммунные заболевания в неврологии (под ред. И.А. Завалишина, М.А. Пирадова, А.Н. Бойко, С.С. Никитина, Н.Н. Спирина, А.В. Переседовой). Клиническое руководство. – Т. 2. – М.: РООИ «Здоровье человека», 2014. – С. 63-75.
Куренков А.Л., Бурсагова Б.И., Кузенкова Л.М., Пак Л.А., Увакина Е.В. Хроническая воспалительная демиелинизирующая полинейропатия в детском возрасте: критерии диагноза и подходы к патогенетическому лечению. Фарматека. 2019. Т.26. №10. С.21-26.
Ghaemi N., Hasanabadi H., Ashrafzadeh F., Sarvari S., Rahimi H., Hashemian S. Peripheral Neuropathy in Children and Adolescents with Insulin-dependent Diabetes Mellitus. Iran J Child Neurol. 2018 Spring;12(2):83-90
Gorson K.C. An update on the management of chronic inﬂammatory demyelinating polyneuropathy. Ther Adv Neurol Disord. 2012;5(6):359-373.
Orbach H., Katz U., Sherer Y., Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol. 2005 Dec;29(3):173-84
Rajabally Y.A., Varanasi S. Practical electrodiagnostic value of F-wave studies in chronic inﬂammatory demyelinating polyneuropathy. Clin Neurophysiol. 2013;124(1):171-175.
Rossi D.P., Doria Lamba L., Pistorio A., Pedemonte M., Veneselli E., Rossi A. Chronic inﬂammatory demyelinating polyneuropathy of childhood: clinical and neuroradiological ﬁndings. Neuroradiology. 2013;55(10):1233-1239
Parikh S., Bernard G., Leventer R.J., van der Knaap M.S., van Hove J., Pizzino A., McNeill N.H., Helman G., Simons C., Schmidt J.L., Rizzo W.B., Patterson M.C., Taft R.J., Vanderver A.; GLIA Consortium. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2015 Apr;114(4):501-515
Kaplan A., Brannagan T.H. 3rd. Evaluation of patients with refractory chronic inﬂammatory demyelinating polyneuropathy. Muscle Nerve. 2017;55(4):476-482
McMillan H.J., Kang P.B., Jones H.R., Darras BT. Childhood chronic inﬂammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series. Neuromuscul Disord. 2013;23(2):103-111.
Sladky J.T. What is the best initial treatment for childhood chronic inﬂammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin. Muscle Nerve. 2008;38:1638–1643
Eftimov F., Winer J.B., Vermeulen M, de Haan R, van Schaik I.N. Intravenous immunoglobulin for chronic inﬂammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013 Dec 30;12:CD001797
Oaklander A.L., Lunn M.P., Hughes R.A., van Schaik I.N., Frost C., Chalk C.H.. Treatments for chronic inﬂammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev. 2017;1(1):CD010369. Published 2017 Jan 13.
Hughes R.A., Mehndiratta M.M., Rajabally Y.A. Corticosteroids for chronic inﬂammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2017;11(11):CD002062. Published 2017 Nov 29. doi:10.1002/14651858.CD002062.pub4.
Mehndiratta M.M., Hughes R.A., Pritchard J. Plasma exchange for chronic inﬂammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;2015(8):CD003906. Published 2015 Aug 25.
Mahdi-Rogers M., Brassington R., Gunn A.A., van Doorn P.A., Hughes R.A. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inﬂammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2017;5(5):CD003280. Published 2017 May 8
Bansal V.K., Meriggioli M.N. Immunotherapy in the treatment autoimmune neuromuscular disease. In book: Neuromuscular disorders in clinical practice (Eds. B. Katirji, H.J. Kaminski, R.L. Ruff). – New York: Springer, 2014. – P. 341-362.
Silwal A., Pitt M., Phadke R., Mankad K., Davison J.E., Rossor A., DeVile C., Reilly M.M., Manzur A.Y., Muntoni F., Munot P. Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inﬂammatory demyelinating polyradiculoneuropathy. Neuromuscul Disord. 2018 Sep;28(9):757-765
Rodríguez Y., Vatti N., Ramírez-Santana C., Chang C., Mancera-Páez O., Gershwin M.E., Anaya J.M. Chronic inﬂammatory demyelinating polyneuropathy as an autoimmune disease. J Autoimmun. 2019 Aug;102:8-37
Вакцинопрофилактика "Медицинские противопоказания к проведению профилактических прививок препаратами национального календаря прививок" (утв. Главным государственным санитарным врачом РФ от 9 января 2002 г.)
Kuitwaard K., Bos-Eyssen M.E., Blomkwist-Markens P.H., van Doorn P.A. Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst. 2009;14(4):310-315
Шевченко А. В. Хронические воспалительные демиелинизирующие полиневропатии у детей (клиника, диагностика, дифференциальная диагностика) : дис. – Российский Государственный Медицинский Университет, 2007.
Azathioprine: Drug information (https://www.uptodate.com/contents/azathioprine-drug- information?topicRef=5265&source=see_link(
Cyclosporine (ciclosporin) (systemic): Drug information (https://www.uptodate.com/contents/cyclosporine-ciclosporin-systemic-drug- information?topicRef=9217&source=see_link#F8012602)
Elena E Perez, MD, PhDNadine Shehata, MD, MSc, FRCPC Section Editor:Jordan S Orange, PhDDeputy Editors:Jennifer S Tirnauer, Anna M Feldweg, Intravenous immune globulin: Adverse effects (https://www.uptodate.com/contents/intravenous-immune-globulin- adverse-effects?topicRef=5265&source=see_link)
Maricic M, Gluck O. Densitometry in glucocorticoid-induced osteoporosis. J Clin Densitom. 2004 Winter;7(4):359-63.
Laura K. Bachrach, Catherine M. Gordon et al. Bone Densitometry in Children and Adolescents. Pediatrics October 2016, 138 (4) e20162398
Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inﬂammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - ﬁrst revision. Eur J Neurol. 2010 Mar;17(3):356-63.
Mori M, Kuwabara S, Nemoto Y, Tamura N, Hattori T. Concomitant chronic inﬂammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection. J Neurol Sci. 2006 Jan 15;240(1-2):103-6.
Richard A Lewis, Suraj Ashok Muley, Section Editor:Jeremy M Shefner, PhDDeputy Editor:Richard P Goddeau, Jr, DO, FAHChronic inﬂammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis A (https://www.uptodate.com/contents/chronic-inﬂammatory-demyelinating-polyneuropathy-etiology-clinical-features-and-diagnosis? source=history_widget#H3648072611)
Gallant C, Kenny P. Oral glucocorticoids and their complications. A review. J Am Acad Dermatol. 1986 Feb;14(2 Pt 1):161-77.
Dyck PJ, O"Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD, Mokri B, Swift T, Low PA, Windebank AJ. Prednisone improves chronic inﬂammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol. 1982 Feb;11(2):136-41.
van Schaik IN, Eftimov F, van Doorn PA, Brusse E, van den Berg LH, van der Pol WL, Faber CG, van Oostrom JC, Vogels OJ, Hadden RD, Kleine BU, van Norden AG, Verschuuren JJ, Dijkgraaf MG, Vermeulen M. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inﬂammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Mar;9(3):245-53.
Richard A. Lewis, Suraj Ashok Muley, MDSection Editor:Jeremy M Shefner, PhDDeputy Editor:Richard P Goddeau, Jr, DO, FAHA Chronic inﬂammatory demyelinating polyneuropathy: Treatment and prognosis https://www.uptodate.com/contents/chronic- inﬂammatory-demyelinating-polyneuropathy-treatment-and-prognosis? source=history_widget#H483050551
Хайбуллин Т.И., Хабиров Ф.А., Аверьянова Л.А., Ахмедова Г.М., Бабичева Н.Н., Гранатов Е.В. Хроническая воспалительная демиелинизирующая полирадикулоневропатия и патогенетически близкие синдромы: диагностика и лечение Практическая медицина. 2014. № 2(78):21-30. http://pmarchive.ru/xronicheskaya-vospalitelnaya-demieliniziruyushhaya- poliradikulonevropatiya-i-patogeneticheski-blizkie-sindromy-diagnostika-i-lechenie/
Гапешин Р.А., Баранцевич Е.Р., Руденко Д.И., и др. Современные представления о лечении хронической воспалительной демиелинизирующей полинейропатии (обзор литературы) // Ученые записки СПбГМУ им. И. П. Павлова. 2019. №1.
Беневоленская Л.И. Клинические рекомендации. Остеопороз. Диагностика, профилактика и лечение/Под ред. Беневоленская Л.И., Лесняк О.М. – М.: ГЭОТАР- Медиа, 2005. – 176 с.
Селицкий М.М. Современные методы диагностики хронической аоспалительной демиелинизирующей полиневропатии. Научно-практический терапевтический журнал. 4 (44). 2015. 36-42.
Stevens, J. A. E., Llewelyn, G., & Hartley, L. Rituximab as an adjunct to intravenous immunoglobulin in the treatment of chronic inﬂammatory demyelinating polyradiculoneuropathy. European Journal of Paediatric Neurology, 21, e114. doi:10.1016/j.ejpn.2017.04.957